BIOLIPOX

biolipox-logo

Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and inflammatory and rheumatic pain. The company offers its users with current arachidonic acid research. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. It is an established research area that empowers several drugs such as Aspirin, Naproxen, and Singulair. Biolipox is a Sweden-based company that was founded in 2000 and the company was acquired by Orexo on November 23, 2007.

#SimilarOrganizations #Financial #More

BIOLIPOX

Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical

Founded:
2000-01-01

Address:
Solna, Stockholms Lan, Sweden

Country:
Sweden

Status:
Active

Total Funding:
62 M USD


Similar Organizations

am-pharma-logo

AM Pharma

AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.

bioviiix-logo

BIOVIIIx

BIOVIIIx is a biotechnology and pharmaceutical company that develops medicine in the field of rare diseases.

not_available_image

Corticrine

Corticrine operates as a pharmaceutical company that develops new therapies for Alzheimer’s dementia.

ducentis-biotherapeutics-logo

Ducentis BioTherapeutics

Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.

intellihep-logo

IntelliHep

IntelliHep is a spin-out company developing novel drugs for Alzheimers disease and cancer.

ixaltis-logo

Ixaltis

Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.

spinal-cord-therapeutics-gmbh-logo

Spinal Cord Therapeutics GmbH

Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury.

systasy-bioscience-logo

Systasy Bioscience

Systasy Bioscience is a biomedical research has radically changed the view to new treatment strategies.

not_available_image

Triptcor Pharmaceuticals

Triptcor Pharmaceuticals, a start-up based on inflammatory disease.

not_available_image

VitaLeech Bioscience

VitaLeech Bioscience develops a recombinant enzyme for the treat­ment of periodontitis, a form of inflammation of the gum.

Investors List

crédit-lyonnais-private-equity_image

Crédit Lyonnais Private Equity

Crédit Lyonnais Private Equity investment in Series C - Biolipox

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series C - Biolipox

auriga-partners_image

Auriga Partners

Auriga Partners investment in Series C - Biolipox

healthcap_image

HealthCap

HealthCap investment in Series C - Biolipox

apax-partners_image

Apax Partners

Apax Partners investment in Series C - Biolipox

angel-investment-network-ltd_image

Angel Investment Network

Angel Investment Network investment in Series C - Biolipox

auriga-partners_image

Auriga Partners

Auriga Partners investment in Series B - Biolipox

crédit-lyonnais-private-equity_image

Crédit Lyonnais Private Equity

Crédit Lyonnais Private Equity investment in Series B - Biolipox

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series B - Biolipox

apax-partners_image

Apax Partners

Apax Partners investment in Series B - Biolipox

More informations about "Biolipox" on Search Engine